Market delayed in reaction to Novo Nordisk and Eli Lilly’ s GLP-1 pills, says Mizuho’s Jared Holz

Jared Holz, Mizuho, joins ‘Fast Money’ to talk competition in the GLP-1 pill space between Novo Nordisk and Eli Lilly.